Dermal application of nitric oxide in vivo: Kinetics, biological responses, and therapeutic potential in humans

Clinical Pharmacology and Therapeutics

Volumn 91, Issue 6, 2012, Pages 1074-1082

  Oplander C ^a   Romer A ^a   Paunel Gorgulu A ^b   Fritsch, T ^c   Van Faassen, E E ^d   Murtz M ^c   Bozkurt, A ^a   Grieb, G ^a   Fuchs, Paul ^a   Pallua, Norbert ^a   Suschek, C V ^b  

^a RWTH AACHEN UNIVERSITY   (Germany)

^b UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

^c HEINRICH HEINE UNIVERSITY   (Germany)

^d LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

NITRIC OXIDE;

ARTICLE; BLOOD FLOW; IN VIVO STUDY; MICROCIRCULATION; OFF LABEL DRUG USE; PRIORITY JOURNAL; SKIN BIOPSY; SKIN PENETRATION; THROMBOCYTE AGGREGATION; VASODILATATION;

ADMINISTRATION, TOPICAL; ADULT; BLEEDING TIME; CHEMISTRY, PHARMACEUTICAL; DIFFUSION CHAMBERS, CULTURE; ELECTRON SPIN RESONANCE SPECTROSCOPY; FEMALE; HEMODYNAMICS; HUMANS; MALE; METHEMOGLOBIN; MICROCIRCULATION; MIDDLE AGED; NITRIC OXIDE; OINTMENTS; PLATELET AGGREGATION; REGIONAL BLOOD FLOW; SKIN; SKIN ABSORPTION; SURGICAL FLAPS; VASODILATOR AGENTS;

EID: 84861342887     PISSN: 00099236     EISSN: 15326535     Source Type: Journal    
DOI: 10.1038/clpt.2011.366     Document Type: Article

References (47)

1. Isenberg, J.S., Ridnour, L.A., Espey, M.G., Wink, D.A. & Roberts, D.D. Nitric oxide in wound-healing. Microsurgery 25, 442-451 (2005). (Pubitemid 41098675)
2. Weller, R.B. Nitric oxide-containing nanoparticles as an antimicrobial agent and enhancer of wound healing. J. Invest. Dermatol. 129, 2335-2337 (2009).
3. Daniel, R.K. & Kerrigan, C.L. Principles and physiology of skin flap surgery. In: Plastic Surgery, Vol. 1 (ed. McCarthy, J.G.) 225-245 (Saunders, Philadelphia, PA, 1990).
4. Manson, P.N., Anthenelli, R.M., Im, M.J., Bulkley, G.B. & Hoopes, J.E. The role of oxygen-free radicals in ischemic tissue injury in island skin flaps. Ann. Surg. 198, 87-90 (1983). (Pubitemid 13059124)
5. Oshima, H., Inoue, H., Aihara, M., Tomioka, M. & Ishida, H. Physiological roles of endothelium-derived nitric oxide in the epigastric island flaps of rabbits. Ann. Plast. Surg. 39, 608-614 (1997). (Pubitemid 27523183)
6. Sasaki, G.H. & Pang, C.Y. Hemodynamics and viability of acute neurovascular island skin flaps in rats. Plast. Reconstr. Surg. 65, 152-158 (1980). (Pubitemid 10132612)
7. Wang, W.Z. et al. Lack of nitric oxide contributes to vasospasm during ischemia/reperfusion injury. Plast. Reconstr. Surg. 99, 1099-1108 (1997).
8. Chen, L.Y., Nichols, W.W., Hendricks, J.B., Yang, B.C. & Mehta, J.L. Monoclonal antibody to P-selectin (PB1.3) protects against myocardial reperfusion injury in the dog. Cardiovasc. Res. 28, 1414-1422 (1994).
9. Kuo, Y.R., Jeng, S.F., Wang, F.S., Huang, H.C., Wei, F.C. & Yang, K.D. Platelet glycoprotein IIb/IIIa receptor antagonist (abciximab) inhibited platelet activation and promoted skin flap survival after ischemia/reperfusion injury. J. Surg. Res. 107, 50-55 (2002). (Pubitemid 35191812)
10. Massberg, S. et al. Platelet-endothelial cell interactions during ischemia/reperfusion: the role of P-selectin. Blood 92, 507-515 (1998). (Pubitemid 28323713)
11. Araki, H., Muramoto, J., Nishi, K., Jougasaki, M. & Inoue, M. Heparin adheres to the damaged arterial wall and inhibits its thrombogenicity. Circ. Res. 71, 577-584 (1992).
12. J ohnson, P.C. & Barker, J.H. Thrombosis and antithrombotic therapy in microvascular surgery. Clin. Plast. Surg. 19, 799-807 (1992).
13. Miller, C.C., Miller, M.K., Ghaffari, A. & Kunimoto, B. Treatment of chronic nonhealing leg ulceration with gaseous nitric oxide: a case study. J. Cutan. Med. Surg. 8, 233-238 (2004). (Pubitemid 41223722)
14. Kuo, Y.R., Wang, F.S., Jeng, S.F., Lutz, B.S., Huang, H.C. & Yang, K.D. Nitrosoglutathione promotes flap survival via suppression of reperfusion injury-induced superoxide and inducible nitric oxide synthase induction. J. Trauma 57, 1025-1031 (2004). (Pubitemid 39579288)
15. Salas, E., Langford, E.J., Marrinan, M.T., Martin, J.F., Moncada, S. & de Belder, A.J. S-nitrosoglutathione inhibits platelet activation and deposition in coronary artery saphenous vein grafts in vitro and in vivo. Heart 80, 146-150 (1998). (Pubitemid 28389475)
16. Zampolli, A., Basta, G., Lazzerini, G., Feelisch, M. & De Caterina, R. Inhibition of endothelial cell activation by nitric oxide donors. J. Pharmacol. Exp. Ther. 295, 818-823 (2000).
17. van den Heuvel, M.G., Buurman, W.A., Bast, A. & van der Hulst, R.R. Review: Ischaemia-reperfusion injury in flap surgery. J. Plast. Reconstr. Aesthet. Surg. 62, 721-726 (2009).
18. Kuo, Y.R., Wang, F.S., Jeng, S.F., Huang, H.C., Wei, F.C. & Yang, K.D. Nitrosoglutathione modulation of platelet activation and nitric oxide synthase expression in promotion of flap survival after ischemia/reperfusion injury. J. Surg. Res. 119, 92-99 (2004). (Pubitemid 38581991)
19. Um, S.C. et al. Involvement of nitric oxide in survival of random pattern skin flap. Plast. Reconstr. Surg. 101, 785-792 (1998). (Pubitemid 28113787)
20. Zhou, R.H. & Frishman, W.H. The antiplatelet effects of nitrates: is it of clinical significance in patients with cardiovascular disease? Cardiol. Rev. 18, 198-203 (2010).
21. Opländer, C. et al. Whole body UVA irradiation lowers systemic blood pressure by release of nitric oxide from intracutaneous photolabile nitric oxide derivates. Circ. Res. 105, 1031-1040 (2009).
22. Pallua, N., Machens, H.G., Rennekampff, O., Becker, M. & Berger, A. The fasciocutaneous supraclavicular artery island flap for releasing postburn mentosternal contractures. Plast. Reconstr. Surg. 99, 1878-1884; discussion 1885 (1997).
23. Malinski, T., Taha, Z., Grunfeld, S., Patton, S., Kapturczak, M. & Tomboulian, P. Diffusion of nitric oxide in the aorta wall monitored in situ by porphyrinic microsensors. Biochem. Biophys. Res. Commun. 193, 1076-1082 (1993). (Pubitemid 23209704)
24. Lancaster, J.R. Jr. Simulation of the diffusion and reaction of endogenously produced nitric oxide. Proc. Natl. Acad. Sci. USA 91, 8137-8141 (1994). (Pubitemid 24253901)
25. Suschek, C.V., Opländer, C. & van Faassen, E.E. Non-enzymatic NO production in human skin: effect of UVA on cutaneous NO stores. Nitric Oxide 22, 120-135 (2010).
26. Paunel, A.N. et al. Enzyme-independent nitric oxide formation during UVA challenge of human skin: characterization, molecular sources, and mechanisms. Free Radic. Biol. Med. 38, 606-615 (2005). (Pubitemid 40416857)
27. Gibbins, J.M. Platelet adhesion signalling and the regulation of thrombus formation. J. Cell. Sci. 117, 3415-3425 (2004). (Pubitemid 39206382)
28. Gkaliagkousi, E., Ritter, J. & Ferro, A. Platelet-derived nitric oxide signaling and regulation. Circ. Res. 101, 654-662 (2007). (Pubitemid 47494096)
29. Antl, M. et al. IRAG mediates NO/cGMP-dependent inhibition of platelet aggregation and thrombus formation. Blood 109, 552-559 (2007). (Pubitemid 46105953)
30. Sogo, N., Magid, K.S., Shaw, C.A., Webb, D.J. & Megson, I.L. Inhibition of human platelet aggregation by nitric oxide donor drugs: relative contribution of cGMP-independent mechanisms. Biochem. Biophys. Res. Commun. 279, 412-419 (2000). (Pubitemid 32036706)
31. Schinner, E., Salb, K. & Schlossmann, J. Signaling via IRAG is essential for NO/cGMP-dependent inhibition of platelet activation. Platelets 22, 217-227 (2011).
32. Schultess, J., Danielewski, O. & Smolenski, A.P. Rap1GAP2 is a new GTPaseactivating protein of Rap1 expressed in human platelets. Blood 105, 3185-3192 (2005).
33. Bilodeau, M.L. & Hamm, H.E. Regulation of protease-activated receptor (PAR) 1 and PAR4 signaling in human platelets by compartmentalized cyclic nucleotide actions. J. Pharmacol. Exp. Ther. 322, 778-788 (2007). (Pubitemid 47105777)
34. Keh, D., Thieme, A., Kürer, I., Falke, K.J. & Gerlach, H. Inactivation of platelet glycoprotein IIb/IIIa receptor by nitric oxide donor 3-morpholinosydnonimine. Blood Coagul. Fibrinolysis 14, 327-334 (2003). (Pubitemid 36688185)
35. Yoneyama, Y. et al. Plasma nitric oxide levels and the expression of P-selectin on platelets in preeclampsia. Am. J. Obstet. Gynecol. 187, 676-680 (2002).
36. Michelson, A.D. et al. Effects of nitric oxide/EDRF on platelet surface glycoproteins. Am. J. Physiol. 270, H1640-H1648 (1996).
37. Gerzer, R., Karrenbrock, B., Siess, W. & Heim, J.M. Direct comparison of the effects of nitroprusside, SIN 1, and various nitrates on platelet aggregation and soluble guanylate cyclase activity. Thromb. Res. 52, 11-21 (1988). (Pubitemid 18267483)
38. Opländer, C. & Suschek, C.V. New aspects of nitrite homeostasis in human skin. J. Invest. Dermatol. 129, 820-822 (2009).
39. Mowbray, M., Tan, X., Wheatley, P.S., Rossi, A.G., Morris, R.E. & Weller, R.B. Topically applied nitric oxide induces T-lymphocyte infiltration in human skin, but minimal inflammation. J. Invest. Dermatol. 128, 352-360 (2008).
40. Opländer, C. et al. A new method for sustained generation of ultra-pure nitric oxide-containing gas mixtures via controlled UVA-photolysis of nitrite solutions. Nitric Oxide 23, 275-283 (2010).
41. Suschek, C.V., Paunel, A. & Kolb-Bachofen, V. Nonenzymatic nitric oxide formation during UVA irradiation of human skin: experimental setups and ways to measure. Meth. Enzymol. 396, 568-578 (2005). (Pubitemid 41603577)
42. Feelisch, M. et al. Concomitant S-, N-, and heme-nitros(yl)ation in biological tissues and fluids: implications for the fate of NO in vivo. FASEB J. 16, 1775-1785 (2002). (Pubitemid 35340358)
43. Marley, R., Feelisch, M., Holt, S. & Moore, K. A chemiluminescense- based assay for S-nitrosoalbumin and other plasma S-nitrosothiols. Free Radic. Res. 32, 1-9 (2000). (Pubitemid 30010603)
44. Beckert, S., Witte, M.B., Königsrainer, A. & Coerper, S. The impact of the Micro-Lightguide O2C for the quantification of tissue ischemia in diabetic foot ulcers. Diabetes Care 27, 2863-2867 (2004). (Pubitemid 39565050)
45. Clinical and Laboratory Standards Institute (CLSI). Platelet Function Testing by Aggregometry; Approved Guideline. CLSI document H58-A, Vol. 28, No. 31, 1-43 (ISBN 1-56238-683-2)
46. Cattaneo, M., Hayward, C.P., Moffat, K.A., Pugliano, M.T., Liu, Y. & Michelson, A.D. Results of a worldwide survey on the assessment of platelet function by light transmission aggregometry: a report from the platelet physiology subcommittee of the SSC of the ISTH. J Thromb Haemost 7, 1029 (2009).
47. Mielke, C.H. Jr, Kaneshiro, M.M., Maher, I.A., Weiner, J.M. & Rapaport, S.I. The standardized normal Ivy bleeding time and its prolongation by aspirin. Blood 34, 204-215 (1969).